Indian generics makers have turned to a Washington, DC, consulting firm run by Ron Somers to counter its tarnished image as bad press from plant bans has put its standards into question.
written on 30.06.2014
Indian generics makers have turned to a Washington, DC, consulting firm run by Ron Somers to counter its tarnished image as bad press from plant bans has put its standards into question.
See our Cookie Privacy Policy Here